Paranasal sinus disorder
MONDO:0001735A disease involving the paranasal sinus.
Also known as: disease of paranasal sinus, disease or disorder of paranasal sinus, disorder of paranasal sinus, paranasal sinus disease, paranasal sinus disease or disorder, paranasal sinus disorder, sinus disorder
163 clinical trials for this condition and its sub-types, 12 tagged with Paranasal sinus disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Paranasal sinus disorder
-
Sinusitis 44 trials · 131 incl. sub-types
5 sub-types
- Chronic rhinosinusitis 90 trials · 92 incl. sub-types Sub-types →
- Maxillary sinusitis 5 trials · 7 incl. sub-types Sub-types →
- Frontal sinusitis 2 trials Sub-types →
- Ethmoid sinusitis 0 trials Sub-types →
- Sphenoid sinusitis 0 trials Sub-types →
-
Paranasal sinus neoplasm 5 trials · 29 incl. sub-types
6 sub-types
- Paranasal sinus cancer 4 trials · 24 incl. sub-types Sub-types →
- Maxillary sinus neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Ethmoidal sinus neoplasm 0 trials Sub-types →
- Frontal sinus neoplasm 0 trials Sub-types →
- Paranasal sinus Schneiderian papilloma 0 trials Sub-types →
- Sphenoidal sinus neoplasm 0 trials Sub-types →
-
Maxillary sinus cholesteatoma 0 trials
-
Polyp of ethmoidal sinus 0 trials
-
Polyp of frontal sinus 0 trials
-
Polyp of maxillary sinus 0 trials
-
Polyp of sphenoidal sinus 0 trials
Most studied deeper sub-types
-
Can a new drug shrink nasal polyps and restore smell?
Disease control Not yet recruitingThis phase 3 trial tests whether the experimental drug felcorekibart, added to standard care, can reduce nasal polyps and improve symptoms like nasal blockage and loss of smell in adults with chronic rhinosinusitis with nasal polyps. Participants receive either felcorekibart or a…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new drug shrink nasal polyps and restore smell?
Disease control Not yet recruitingThis phase 3 trial tests whether an experimental drug called felcorekibart can reduce nasal polyps and improve symptoms like nasal blockage and loss of smell in adults with chronic rhinosinusitis with nasal polyps. Participants receive either felcorekibart or a placebo on top of …
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC